URSO, LOREDANA
 Distribuzione geografica
Continente #
NA - Nord America 2.594
AS - Asia 962
EU - Europa 821
SA - Sud America 217
AF - Africa 186
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.801
Nazione #
US - Stati Uniti d'America 2.471
SG - Singapore 349
CN - Cina 183
HK - Hong Kong 176
IT - Italia 172
DE - Germania 165
BR - Brasile 152
FI - Finlandia 93
SE - Svezia 60
PL - Polonia 53
FR - Francia 43
VN - Vietnam 38
RU - Federazione Russa 31
GB - Regno Unito 29
NL - Olanda 25
IN - India 22
CA - Canada 19
KR - Corea 15
MX - Messico 15
AR - Argentina 14
UA - Ucraina 12
ES - Italia 11
PY - Paraguay 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
GH - Ghana 10
IE - Irlanda 10
IL - Israele 10
RO - Romania 10
YE - Yemen 10
ZA - Sudafrica 10
CR - Costa Rica 9
JO - Giordania 9
JP - Giappone 9
BW - Botswana 8
DO - Repubblica Dominicana 8
MA - Marocco 8
ME - Montenegro 8
MR - Mauritania 8
RW - Ruanda 8
TH - Thailandia 8
TR - Turchia 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
AZ - Azerbaigian 7
HT - Haiti 7
KH - Cambogia 7
LA - Repubblica Popolare Democratica del Laos 7
MK - Macedonia 7
PE - Perù 7
PR - Porto Rico 7
SN - Senegal 7
TJ - Tagikistan 7
AO - Angola 6
BB - Barbados 6
CI - Costa d'Avorio 6
CY - Cipro 6
IQ - Iraq 6
MD - Moldavia 6
PA - Panama 6
PH - Filippine 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
UG - Uganda 6
ZM - Zambia 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BF - Burkina Faso 5
CG - Congo 5
CH - Svizzera 5
CO - Colombia 5
CV - Capo Verde 5
DJ - Gibuti 5
GA - Gabon 5
GP - Guadalupe 5
ID - Indonesia 5
IR - Iran 5
MY - Malesia 5
NE - Niger 5
UY - Uruguay 5
UZ - Uzbekistan 5
VC - Saint Vincent e Grenadine 5
BE - Belgio 4
BJ - Benin 4
BY - Bielorussia 4
BZ - Belize 4
CM - Camerun 4
CU - Cuba 4
DK - Danimarca 4
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
GF - Guiana Francese 4
HR - Croazia 4
JM - Giamaica 4
KE - Kenya 4
LC - Santa Lucia 4
ML - Mali 4
MN - Mongolia 4
Totale 4.640
Città #
Fairfield 451
Ashburn 229
Singapore 227
Chandler 206
Woodbridge 173
Hong Kong 170
Houston 139
Cambridge 133
Munich 126
Seattle 125
Wilmington 111
San Diego 98
Helsinki 68
Santa Clara 61
Ann Arbor 59
Boardman 51
Bytom 48
Beijing 47
Padova 46
Medford 39
Princeton 39
Guangzhou 35
Des Moines 25
Roxbury 21
New York 20
Los Angeles 18
Hefei 15
São Paulo 14
Milan 13
Shanghai 13
Buffalo 10
Ho Chi Minh City 10
Seoul 10
Turku 10
Accra 9
Amman 9
Hanoi 9
London 9
Dublin 8
Kigali 8
Nanjing 8
Ottawa 8
Villafranca Padovana 8
Bangkok 7
Dakar 7
Nouakchott 7
Vientiane 7
Abidjan 6
Belo Horizonte 6
Brooklyn 6
Dushanbe 6
Johannesburg 6
Kampala 6
Luanda 6
Lusaka 6
Nanchang 6
Ogden 6
Panama City 6
Paris 6
Phnom Penh 6
San José 6
Tel Aviv 6
Abu Dhabi 5
Aden 5
Amsterdam 5
Baku 5
Bridgetown 5
Dong Ket 5
Jyväskylä 5
Libreville 5
Montevideo 5
Ouagadougou 5
Podgorica 5
Rome 5
San Francisco 5
Sanaa 5
Tashkent 5
Vienna 5
Bamako 4
Belize City 4
Ciudad del Este 4
Cotonou 4
Dallas 4
Djibouti 4
Gaborone 4
Guayaquil 4
Hsinchu County 4
Istanbul 4
Kharkiv 4
Kingstown 4
Maitengwe 4
Minsk 4
Montreal 4
Niamey 4
Phoenix 4
Port Moresby 4
Port-au-Prince 4
Redondo Beach 4
Rio de Janeiro 4
San Juan 4
Totale 3.222
Nome #
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 268
211P: Inflammatory cells characterization and localization in malignant pleural mesothelioma (MPM) tissue samples: Correlation with histologic subtype and prognosis 223
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study 223
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time 173
Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma 162
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists 161
Metabolic rewiring and redox alterations in malignant pleural mesothelioma 161
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers 147
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells 144
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 141
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer 139
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: Correlation with pathological and clinical data 134
Liquid biopsy in malignant pleural mesothelioma: State of the art, pitfalls, and perspectives 134
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 131
Effects of sulfonylureas on tumor growth: A review of the literature 129
Synergistic antitumor activity of recombinant human Apo2L/Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma 122
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 119
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment 118
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer 117
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification 114
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial 106
Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metalloproteinase activity 105
Functions of epidermal growth factor receptor in cisplatin response of thyroid cells 102
Effects of cisplatin on matrix metalloproteinase-2 in transformed thyroid cells 101
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 101
Epigenetic Regulation of miR-212 Expression in Lung Cancer 97
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype 90
Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells 89
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells 88
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED 87
Anti-apoptotic effects of protein kinase C-δ and c-fos in cisplatin-treated thyroid cells 83
[Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 82
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment 82
Mesothelin-targeted agents in mesothelioma 80
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus 72
Targeted therapies in mesothelioma 72
Sublethal concentrations of the platinum(II) complex [Pt(O,O′-acac) (γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells 71
New platinum(II) complexes containing both an O,O′-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells 71
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets 60
Serum osteoprotegerin correlates with age and bone mass in postmenopausal, but not in fertile age women 59
[Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway (British Journal of Pharmacology (2007) 153, (34-49) DOI: 10.1038/sj.bjp.0707646) 58
PKC-ε-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC C13 cells 58
Totale 4.874
Categoria #
all - tutte 17.829
article - articoli 17.300
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 529
Totale 35.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021522 0 0 20 15 15 41 163 20 75 53 47 73
2021/2022724 40 44 38 15 74 198 35 33 43 68 37 99
2022/2023455 68 57 22 49 60 40 4 26 79 10 31 9
2023/2024289 17 42 41 23 12 42 22 3 10 35 22 20
2024/20251.293 16 111 46 61 131 40 114 159 138 39 186 252
2025/20261.027 195 332 500 0 0 0 0 0 0 0 0 0
Totale 4.874